Associate Professor of Urology and Oncology
Radiation Oncology and Molecular Radiation Sciences
The Johns Hopkins University School of Medicine
Dr. Daniel (Danny) Song is an Associate Professor of urology, oncology, and radiation oncology at the Johns Hopkins School of Medicine. He serves as the co-director of the Prostate Cancer Multidisciplinary Clinic at the Johns Hopkins School of Medicine and the Physician Advisor and Director of Faculty Affairs for the Department of Radiation Oncology and Molecular Radiation Sciences. His area of clinical expertise is in the management of genitourinary cancers, including cancers of the prostate, bladder and urinary tract, and testicular cancer.
Dr. Song's applies his expertise in the utilization of a variety of radiation modalities including external beam radiation, image-guided and intensity-modulated radiation, prostate brachytherapy (seed implants), and stereotactic body radiation therapy.
Dr. Song's research interests include the development and refinement of new imaging methods to improve radiation targeting, as well as innovative means of reducing potential side effects of radiation treatment. His research efforts have been sponsored and funded by competitive grants from organizations such as the Department of Defense, the National Cancer Institute, and the American Cancer Society.
He is board-certified, and also a member of the examination committee for the American Board of Radiology, which administers the board certification process for radiation oncologists nationwide. He serves on the editorial board of the International Journal of Radiation Oncology, Biology, and Physics, the premier research journal for radiation oncology, and on the scientific review committees for the American Society for Radiation Oncology (ASTRO) and American Brachytherapy Society. He also participated in writing practice consensus guidelines on stereotactic body radiation therapy (TG-101) and image-guided robotic brachytherapy (TG-192) produced by the American Association of Physics in Medicine.